HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hydrocodone Bitartrate And Homatropine Methylbromide, and when can generic versions of Hydrocodone Bitartrate And Homatropine Methylbromide launch?
Hydrocodone Bitartrate And Homatropine Methylbromide is a drug marketed by Abhai Llc, Actavis Mid Atlantic, Apozeal Pharms, Genus, Ivax Sub Teva Pharms, Nostrum Labs Inc, Novel Labs Inc, Padagis Us, and Wockhardt Bio Ag. and is included in nine NDAs.
The generic ingredient in HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE is homatropine methylbromide; hydrocodone bitartrate. There are five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the homatropine methylbromide; hydrocodone bitartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hydrocodone Bitartrate And Homatropine Methylbromide
A generic version of HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE was approved as homatropine methylbromide; hydrocodone bitartrate by AVANTHI INC on August 7th, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE?
- What are the global sales for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE?
- What is Average Wholesale Price for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE?
Summary for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
US Patents: | 0 |
Applicants: | 9 |
NDAs: | 9 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
What excipients (inactive ingredients) are in HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE? | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE excipients list |
DailyMed Link: | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE at DailyMed |
Pharmacology for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
Drug Class | Opioid Agonist |
Mechanism of Action | Opioid Agonists |